What tumor markers are tested for lung cancer?
Lung cancer can typically be screened through tumor markers such as carcinoembryonic antigen (CEA), cytokeratin 19 fragment antigen (CYFRA 21-1), and squamous cell carcinoma antigen (SCC-Ag). Detailed analysis is as follows:
1. Carcinoembryonic Antigen (CEA)
This is an acidic glycoprotein exhibiting characteristics of human embryonic antigens, serving as a marker for diseases such as lung and colorectal cancers to help determine whether malignant cellular transformation has occurred. A level greater than 5.0 ng/mL warrants concern for possible malignancy.
2. Cytokeratin 19 Fragment Antigen (CYFRA 21-1)
This is a relatively new tumor marker for detecting lung cancer and holds significant value in diagnosing non-small cell lung cancer. If the serum concentration exceeds 3.3 ng/mL, lung cancer may be present.
3. Squamous Cell Carcinoma Antigen (SCC-Ag)
This antigen primarily exists in squamous epithelial cells. Since the lungs also contain abundant squamous epithelium, SCC-Ag can serve as a tumor marker for lung cancer to assess the presence or recurrence of the disease. A positive test result suggests either active lung cancer or recurrence.
In addition, other markers such as neuron-specific enolase (NSE) may also be tested. Once lung cancer is confirmed through tumor marker testing, it is recommended to promptly initiate standardized treatment under a physician's guidance to control disease progression.